Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cancer immunotherapeutics

Anti-cancer immunotherapeutics

US Patent 5693522 · Granted Dec 2, 1997

Estimated economic value: $12,573,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132025
Recombinant vectors comprising 2A peptide2022
Retroviral vector having immune-stimulating activity2022
Formulations of 5-fluorocytosine and uses thereof2021
Retroviral vector with mini-promoter cassette2021
Producer cells for replication competent retroviral vectors2021
Vectors conditionally expressing therapeutic proteins, host cells comprising the2020
Formulations of 5-fluorocytosine and uses thereof2019
Recombinant vectors2019
Producer cells for replication competent retroviral vectors2019
Gene therapy vectors and cytosine deaminases2018
Formulations of 5-fluorocytosine and uses thereof2018